SIRPA and cancer: Using a similar strategy, exosomes expressing signal-regulatory protein alpha (SIRPα) on the membrane surface were constructed that can avoid failed immune surveillance via blocking the recognition of CD47 (expressed by tumor cells) by immune cells, leading to enhanced phagocytic ability of macrophages and inhibited growth of cancer cells in vivo (9, 10).